Related Experiment Videos

[The complement system in familial Mediterranean fever: studies in 41 families (author's transl)]

Annales De Medecine Interne
|January 1, 1981
PubMed

Insights

Familial Mediterranean fever shows increased blood complement C4 levels, unaffected by colchicine therapy. This finding, distinct from other protein changes, aids in diagnosing this inflammatory syndrome.

Area of Science:

  • Biochemistry
  • Immunology
  • Pathophysiology

Context:

  • Familial Mediterranean fever (FMF) is a genetic autoinflammatory disorder.
  • Current diagnostic markers for FMF are primarily clinical.
  • Understanding FMF's biochemical alterations is crucial for improved diagnostics.

Purpose:

  • To investigate the changes in blood complement components, specifically C4, in patients with familial Mediterranean fever.
  • To compare these changes with other serum proteins like haptoglobin and orosomucoid before and after colchicine treatment.
  • To evaluate the diagnostic potential of complement component alterations in FMF.

Summary:

  • Elevated levels of blood complement components, particularly C4, were observed in familial Mediterranean fever patients.
  • These increases persisted both before and after colchicine therapy.
  • This pattern contrasts with the decrease in serum haptoglobin and orosomucoid concentrations following therapy.

Impact:

  • The distinct pattern of complement component changes offers potential diagnostic value for familial Mediterranean fever.
  • These alterations may stem from both hepatic and extrahepatic sources.
  • Extrahepatic origins might involve the uptake of circulating monocytes by connective tissue in the sub-mesothelial layer, contributing to the pathology.

Related Concept Videos